|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Oct 19, 2021 |
Title |
Lung_2 |
Sample type |
SRA |
|
|
Source name |
unfractionated lung tissue
|
Organism |
Mus musculus |
Characteristics |
tissue: lung strain: BALB/cJ treatment: OVA/OM-85 Sex: Male bal eosinophils (percent): 0.5 ahr slope (z-score): -0.879181504134179
|
Treatment protocol |
Balb/c mice (7-8 weeks old) were sensitized intra-peritoneally (i.p.) with OVA (chicken egg white albumin, Sigma: 20 ug) + Alum (Imject Alum, Thermo Fisher: 50 ul) at day 0 and 14 and challenged i.n. with OVA (50 ug) 6 at day 28 and 38. OM-85 (1 mg in 0.9% saline/treatment x 14 treatments) was administered i.n, 25 ul/nostril, under light anesthesia (1-5% isoflurane) every 2-3 days from day 0. Control mice received PBS at the time of sensitization, challenge and treatment. Unfractionated lung tissue was collected at day 39 and processed for RNA-sequencing.
|
Extracted molecule |
polyA RNA |
Extraction protocol |
total RNA was isolated using RNeasy mini kits (Qiagen) and mRNA capture (polyA enrichment) was achieved using oligo(dT)25 Dynabeads (ThermoFisher) cDNA libraries were constructed using KAPA Biosystems kits (Roche)
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 4000 |
|
|
Description |
AD02
|
Data processing |
Adapter sequences were trimmed from RNA-seq reads (fastq files) and only reads >25bp long were included in the analysis Reads were mapped to the BALB/cJ genome (version mm10) using STAR and genomic coordinates were shifted to the standard mm10 genome using MARGE HOMER was used to select uniquely aligning reads and to generate gene counts. A maximum of 3 clones/read was included to minimize bias due to PCR amplification. Expression data were estimated for 24,538 genes and were filtered to include only genes with at least one read in 20% of the samples, which retained a total of 19,613 genes. RUVSeq was used to estimate latent factors of unwanted variation (3 RUVs) that were included as covariates in differential expression analysis. Differential expression analysis was performed using DESeq2 and differentially expressed genes were defined as having an FDR-adjusted P-value <0.05 and a |log2 fold change| >0.5. Genome_build: mm10 Supplementary_files_format_and_content: Matrix table with raw gene counts for every gene and every sample Supplementary_files_format_and_content: tab-delimited text file including normalized counts (rlog transformation) for each sample
|
|
|
Submission date |
Feb 27, 2021 |
Last update date |
Oct 19, 2021 |
Contact name |
Donata Vercelli |
Organization name |
University of Arizona
|
Street address |
1657 E. Helen St.
|
City |
Tucson |
State/province |
Arizona |
ZIP/Postal code |
85721 |
Country |
USA |
|
|
Platform ID |
GPL21103 |
Series (1) |
GSE167867 |
Intranasal administration of OM-85, a bacterial lysate, alters lung transcriptional profiles and protects against experimental asthma |
|
Relations |
BioSample |
SAMN18083164 |
SRA |
SRX10184377 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|